BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 15816962)

  • 1. Valproate-induced proximal renal tubular dysfunction: clinically relevant in the severely disabled epileptic population.
    Jaffe SL; Sanford M
    Epilepsia; 2005 Apr; 46(4):599-600. PubMed ID: 15816962
    [No Abstract]   [Full Text] [Related]  

  • 2. Fanconi syndrome caused by valproic acid.
    Endo A; Fujita Y; Fuchigami T; Takahashi S; Mugishima H
    Pediatr Neurol; 2010 Apr; 42(4):287-90. PubMed ID: 20304335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fanconi syndrome caused by sodium valproate: report of three severely disabled children.
    Yoshikawa H; Watanabe T; Abe T
    Eur J Paediatr Neurol; 2002; 6(3):165-7. PubMed ID: 12363104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium valproate-induced Fanconi syndrome in two severely disabled patients receiving carnitine supplementation.
    Ono H
    Clin Exp Nephrol; 2019 Jan; 23(1):148-149. PubMed ID: 29679355
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcome of renal proximal tubular dysfunction with Fanconi syndrome caused by sodium valproate.
    Yamazaki S; Watanabe T; Sato S; Yoshikawa H
    Pediatr Int; 2016 Oct; 58(10):1023-1026. PubMed ID: 26896192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fanconi syndrome caused by antiepileptic therapy with valproic Acid.
    Knorr M; Schaper J; Harjes M; Mayatepek E; Rosenbaum T
    Epilepsia; 2004 Jul; 45(7):868-71. PubMed ID: 15230715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of oligoasthenozoospermia in epileptic patients on switching anti-epilepsy medication from sodium valproate to phenytoin.
    Hayashi T; Yoshida S; Yoshinaga A; Ohno R; Ishii N; Yamada T
    Scand J Urol Nephrol; 2005; 39(5):431-2. PubMed ID: 16257847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary renal Fanconi syndrome caused by valproate therapy.
    Watanabe T; Yoshikawa H; Yamazaki S; Abe Y; Abe T
    Pediatr Nephrol; 2005 Jun; 20(6):814-7. PubMed ID: 15785938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune haemolytic anaemia and renal Fanconi syndrome caused by valproate therapy.
    Watanabe T; Nakayasu K; Nagayama Y
    Eur J Pediatr; 2005 Mar; 164(3):186-7. PubMed ID: 15717181
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders.
    Otoom S; Bakhiet M; Khan A; Sequeira R
    Neuro Endocrinol Lett; 2006; 27(1-2):85-8. PubMed ID: 16648782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of sodium valproate on the renal function of children with epilepsy.
    Knights MJ; Finlay E
    Pediatr Nephrol; 2014 Jul; 29(7):1131-8. PubMed ID: 23720013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney Biopsy Findings in a Patient With Valproic Acid-Associated Fanconi Syndrome.
    Singer P; Sethna CB; Castellanos-Reyes L; Yaskiv O; Bijol V
    Pediatr Dev Pathol; 2019; 22(4):370-374. PubMed ID: 30565480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate-associated coagulopathies are frequent and variable in children.
    Attilakos A; Katsarou E; Voudris K; Garoufi A
    Epilepsia; 2007 Jan; 48(1):205-6. PubMed ID: 17241231
    [No Abstract]   [Full Text] [Related]  

  • 14. Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy.
    Voudris KA; Attilakos A; Katsarou E; Drakatos A; Dimou S; Mastroyianni S; Skardoutsou A; Prassouli A; Garoufi A
    Epilepsy Res; 2006 Aug; 70(2-3):211-7. PubMed ID: 16781120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal tubular dysfunction in epileptic children on valproic acid therapy.
    Altunbaşak S; Yildizaş D; Anarat A; Burgut HR
    Pediatr Nephrol; 2001 Mar; 16(3):256-9. PubMed ID: 11322374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovary syndrome associated with treatment with the anticonvulsant sodium valproate.
    Sharma S; Jacobs HS
    Curr Opin Obstet Gynecol; 1997 Dec; 9(6):391-2. PubMed ID: 9425584
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hyperammonemia during sodium valproate therapy: clinically relevant or accidental finding?].
    Ettlin T; Scollo-Lavizzari G
    Schweiz Rundsch Med Prax; 1986 Jul; 75(29):881-5. PubMed ID: 3090672
    [No Abstract]   [Full Text] [Related]  

  • 18. Tubulo-interstitial nephritis caused by sodium valproate.
    Yoshikawa H; Watanabe T; Abe T
    Brain Dev; 2002 Mar; 24(2):102-5. PubMed ID: 11891102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precocious puberty in an epileptic child treated with valproate.
    Zaiem A; Aouinti I; Lakhoua G; Kastalli S; Daghfous R; Lakhal M; El Aïdli S
    Therapie; 2012; 67(6):537-8. PubMed ID: 23249581
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticonvulsant-induced rickets and nephrocalcinosis.
    Lau KK; Papneja K
    BMJ Case Rep; 2012 Feb; 2012():. PubMed ID: 22665570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.